Lulu Li from 858 Oakhill Ln, Yardley, PA 19067, age 44

Professional Records

Lawyers & Attorneys

Lulu Li - Lawyer

View page

Office:

Davis Polk & Wardwell LLP

Specialties:

Corporate Law

ISLN:

922292805

Admitted:

2015

University:

Fordham University School of Law; University of Queensland, B.Com., 1999

Law School:

University of Queensland, Ll.B., 2000; University of Melbourne, Ll.M., 2003

Lulu Li - Lawyer

View page

ISLN:

924360366

Admitted:

2015

Resumes

Lulu Li

View page

Lulu Li

View page

Lulu Li

View page

Lulu Li

View page

Location:

United States

Lulu Li

View page

Location:

United States

Lulu Li Rego Park, NY

View page

Work:

Universal Processing LLC

Jun 2012 to 2000
Operation Manager
HSBC

Jun 2011 to Aug 2011
Financial Analyst InternCommercial Banking Department
Chongqing Iron & Steel
Hong Kong, Hong Kong Island
May 2009 to Sep 2009
Financial Accountant Intern, Accounting Department
Chongqing Iron & Steel Co., Ltd

Aug 2008 to Sep 2008
Accountant Intern, Accounting Department
Golden Five Accounting Firm

Jun 2008 to Aug 2008
Internal Auditor, Auditing Department

Education:

Polytechnic Institute of New York University
New York, NY
Sep 2010 to Jun 2012
MS in Financial Engineering
NYU-poly
New York, NY
Sep 2010 to Dec 2011
Chinese
Nanchang University
Sep 2006 to Jul 2010
Bachelor in International Trade
improving center of Nanchang University
mental & physical

Lulu Li Hillsborough, NJ

View page

Work:

MoneyGram International
Lakewood, CO
Nov 2010 to Apr 2011
Consumer Support Specialist
Rider University
Lawrenceville, NJ
Sep 2009 to Dec 2009
Independent Researcher
Rider University
Lawrenceville, NJ
Mar 2007 to Sep 2008
Laboratory Assistant
Capital Health System
Trenton, NJ
Jan 2008 to Feb 2008
Intern
Paramount Gymnastics
Hillsborough, NJ
Sep 2005 to May 2006
Gymnastics Instructor

Education:

Grand Canyon University
Phoenix, AZ
2011 to 2013
Masters in Public Health
Rider University
Lawrenceville, NJ
May 2010
Bachelor of Science in Biochemistry

Skills:

NMR, IR, GC, Centrifuge, Sonicator, Spectrophotometer, Kugelrohr, Rotovap, Bio-Rad Assay, SDS-PAGE, Ligation, Protein Purification, Reflux, Bacterial Transformation, Bacteria Cultures, TLC, DNA Isolation, and Enzymatic Activity Measurement, Microsoft Word, Excel, PowerPoint, Project, Internet, E-mail, Social Networking, Fluent in both English and Chinese.

Lulu Li Stamford, CT

View page

Work:

JP Morgan Chase & Co

Oct 2013 to 2000
Business Analyst
JP Morgan Chase & Co

Jul 2013 to 2000
Operation Analyst
Wealthlink Capital Holdings LLC
Princeton, NJ
Jul 2011 to Jun 2013
Financial Analyst
New York University
New York, NY
Feb 2011 to Jul 2011
Bloomberg Trainer, Teaching Assistant, Research Assistant

Education:

Anhui University
Sep 2008 to May 2010
CFA
New York University
New York, NY
Master of Science in Financial and Risk Management

Publications

Us Patents

Therapeutic Encapsulated Embryonic Stem Cells And Mesenchymal Stromal Cells

View page

US Patent:

20120020931, Jan 26, 2012

Filed:

Jun 2, 2011

Appl. No.:

13/151912

Inventors:

Martin L. Yarmush - Newton MA, US
Rene S. Schloss - East Brunswick NJ, US
Martin Grumet - New York NY, US
Jeffrey Barminko - Old Bridge NJ, US
Jae Hwan Kim - Highland Park NJ, US
Tim Maguire - Piscataway NJ, US
Jean-Pierre Dolle - Metuchen NJ, US
Lulu Li - New Brunswick NJ, US

Assignee:

RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY - New Brunswick NJ

International Classification:

C12N 11/10
A61P 25/00
A61K 35/12

US Classification:

424 937, 435178

Abstract:

This application discloses alginate microencapsulation-mediated differentiation of embryonic stem cells and use of the stem cell differentiation method for the development of effective treatment of various diseases and disorders. The microencapsulation of embryonic stem (ES) cells results in decreased cell aggregation and enhanced neural lineage differentiation through incorporating the soluble inducer retinoic acid (RA) into the permeable microcapsule system. This application also discloses a micro-encapsulation system for immobilizing mesenchymal stromal cells (MSCs) while sustaining the molecular communication. Thus, the invention provides the use of encapsulated mesenchymal stromal cells in the cellular transplantation therapies. Moreover, the invention provides methods for delivery of encapsulated MSCs into the central nervous system and therapies derived therefrom, such as, the treatment of spinal cord injury (SCI) and other inflammatory conditions.

Videos & Images